Lifeway Foods, Inc.
- Open
- 26.25
- Day high
- 26.59
- Day low
- 25.97
- Prev close
- 26.35
- Volume
- 92K
- Mkt cap
- $393M
- P/E (TTM)
- 36.2
- EPS (TTM)
- $0.72
- P/B
- 4.6
- P/S
- 1.6
- Yield
- —
- Per share
- —
- ▼Insiders net selling -$14.0M over the last 3 months (4 open-market buys, 20 sales)
- ◆Cluster buying — multiple insiders bought within days
- 🏛Institutions accumulating (13F)
Lifeway Foods, Inc. (LWAY) is a Consumer Defensive company listed on NASDAQ. The stock is down 11% over the past year. Over the trailing 3 months, insiders filed 4 open-market buys and 20 sales (SEC Form 4).
Lifeway Foods, Inc. (LWAY) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
LWAY earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 13, 2026 | $0.27 | $0.01 | -96.2% | $67M | +8.9% |
| May 14, 2026 | $0.30 | $0.30 | +0.0% | $63M | +3.6% |
| Mar 17, 2026 | $0.29 | $0.16 | -44.8% | $55M | +0.7% |
| Nov 12, 2025 | $0.28 | $0.23 | -17.9% | $57M | +3.9% |
| Aug 12, 2025 | $0.18 | $0.28 | +55.6% | $54M | -2.0% |
| Mar 14, 2025 | $0.21 | $-0.01 | -104.8% | $47M | -2.2% |
| Nov 14, 2024 | $0.27 | $0.19 | -29.6% | $46M | -3.0% |
| Mar 20, 2024 | $0.21 | $0.26 | +23.8% | $42M | +5.2% |
| Aug 14, 2023 | $0.06 | $0.21 | +250.0% | $39M | +4.6% |
| May 15, 2023 | $0.08 | $0.06 | -25.0% | $38M | +1.1% |
| Nov 14, 2022 | $0.01 | $0.06 | +500.0% | $38M | -2.2% |
| Aug 26, 2022 | — | $-0.06 | — | $34M | — |
LWAY insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | SMOLYANSKY JULIEdirector, 10 percent owner, officer: CEO, President and Secretary | Buy | 2,000 | $25.26 |
| Aug 17, 2026 | Divisadero Street Capital Management, LP10 percent owner | Buy | 35,952 | $24.78 |
| Aug 17, 2026 | Divisadero Street Capital Management, LP10 percent owner | Buy | 195,616 | $24.87 |
| Aug 17, 2026 | Divisadero Street Capital Management, LP10 percent owner | Buy | 15,000 | $24.69 |
| Aug 14, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 31 | $26.50 |
| Aug 14, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 35,000 | $28.74 |
| Aug 14, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 45,038 | $25.82 |
| Aug 14, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 29,931 | $24.89 |
| Jul 23, 2026 | SMOLYANSKY LUDMILAother: Member of 10% owner group | Sell | 40,000 | $29.46 |
| Jul 23, 2026 | SMOLYANSKY LUDMILAother: Member of 10% owner group | Sell | 60,000 | $30.55 |
| Jul 16, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 42,263 | $32.32 |
| Jul 16, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 24,653 | $31.51 |
| Jul 9, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 7,984 | $29.79 |
| Jul 9, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 39,098 | $29.41 |
| Jul 2, 2026 | SMOLYANSKY EDWARD10 percent owner | Sell | 14,542 | $30.12 |
Source: LWAY SEC Form 4 filings, latest Aug 19, 2026. For informational purposes only — not investment advice.
See the full LWAY insider & 13F page →Lifeway Foods, Inc. company profile
Overview
Lifeway Foods, Inc. (NASDAQ:LWAY) is a specialty food manufacturer founded in 1986 and based in Morton Grove, Illinois. The company went public in 1988 and has established itself as the leading producer of kefir products in the United States. Over nearly four decades, Lifeway has built its business around probiotic-rich dairy products, with drinkable kefir as its flagship offering. The company has experienced significant growth in recent years, achieving 22 consecutive quarters of net sales growth as of Q1 2025, driven by increasing consumer interest in health and wellness products.
Business
Lifeway Foods operates in the packaged foods industry, specifically within the cultured dairy and probiotic products segment. The company's core business revolves around manufacturing and marketing probiotic-based dairy products, with kefir being the centerpiece of its product portfolio. Kefir is a fermented milk drink that originated in the Caucasus Mountains and is created by adding kefir grains (a combination of bacteria and yeast cultures) to milk. The fermentation process produces a tangy, yogurt-like beverage that contains multiple strains of probiotics - beneficial bacteria that support digestive and immune health. Unlike regular yogurt, kefir typically contains a more diverse array of probiotic cultures and has a thinner, more drinkable consistency. The company's product portfolio includes several key segments: 1. Drinkable Kefir Products (approximately 70-75% of revenue): This flagship category includes various formulations such as low-fat, non-fat, whole milk, protein-enhanced, and organic versions. The company offers numerous flavors and has recently introduced lactose-free options and specialty varieties like BioKefir. 2. Farmer's Cheese and European-Style Soft Cheeses (approximately 10-15% of revenue): Traditional European-style cheeses that complement the core kefir business and appeal to consumers seeking authentic dairy products. 3. Children's Products (approximately 5-10% of revenue): The ProBugs line specifically targets children with kid-friendly flavors and packaging, making probiotic products accessible to younger consumers. 4. Specialty Products (approximately 5-10% of revenue): This includes cupped kefir, Icelandic Skyr (a strained kefir product), frozen kefir, and newer innovations like probiotic smoothies with collagen. The company also engages in private-label manufacturing for other brands, though this represents a declining portion of the business as Lifeway focuses more on its branded products.
Revenue model
Lifeway Foods generates revenue primarily through product sales to retailers, who then sell to end consumers. The company operates a traditional manufacturing and distribution business model, producing its products in company-owned facilities and selling them through multiple channels. The company's revenue streams include: 1. Branded Product Sales (approximately 85-90% of revenue): Lifeway sells its products under the "Lifeway" and "Fresh Made" brand names to grocery retailers, health food stores, club stores like Costco, and increasingly to convenience stores and pharmacies like CVS. Major retail partners include Walmart, Target, Albertsons, Stop & Shop, and Publix. 2. Private Label Manufacturing (approximately 10-15% of revenue): The company produces kefir and related products for other brands, though management has been strategically reducing this lower-margin business to focus on higher-margin branded products. 3. E-commerce and Direct Sales (growing segment): Online sales through Amazon, company website, and retailer e-commerce platforms. Several factors influence Lifeway's profitability margins: Positive margin drivers include the growing health and wellness trend driving premium pricing for probiotic products, the company's dominant market position in kefir allowing for pricing power, operational efficiency improvements from facility investments, and the shift away from lower-margin private label business toward higher-margin branded products. Negative margin pressures come from volatile milk prices (the primary raw material), general food ingredient inflation, increased marketing and promotional spending to drive growth, competitive pressure in the broader yogurt and dairy alternatives market, and retail customer demands for promotional support and slotting fees. The company has demonstrated pricing power during inflationary periods, successfully implementing price increases to offset cost pressures while maintaining volume growth, suggesting strong brand loyalty and category leadership.
Competitive moat
Lifeway Foods possesses a moderate but meaningful competitive moat built primarily around its category leadership and specialized expertise in kefir production. The company controls an estimated 90% of the U.S. kefir market, giving it significant scale advantages and brand recognition in this niche category. The company's moat consists of several elements: Manufacturing expertise in kefir production, which requires specialized knowledge of fermentation processes and probiotic cultures that takes years to develop; established distribution relationships with major retailers who view Lifeway as the category leader; brand recognition among health-conscious consumers who specifically seek out kefir products; and regulatory advantages including FDA-approved health claims for cultured dairy products. However, the moat faces several vulnerabilities. The kefir category, while growing, remains relatively small compared to the broader yogurt market, limiting total addressable market size. Large dairy companies like Danone, Chobani, or General Mills could potentially enter the kefir space with significant resources and existing distribution networks. The rise of plant-based alternatives and non-dairy probiotic products presents a potential disruption, especially as companies develop non-dairy kefir alternatives. Additionally, the broader probiotic supplement market offers consumers alternative ways to obtain similar health benefits through pills, powders, and other formats that may be more convenient or cost-effective than daily kefir consumption. The company's moat is strongest within the traditional kefir category but becomes more questionable when considering the broader competitive landscape of functional foods, probiotics, and health-focused beverages. The key to maintaining competitive advantage will be continued innovation, brand building, and expansion into adjacent categories while leveraging the core kefir expertise.
Risks & safety
Lifeway Foods demonstrates a strong financial safety profile with minimal solvency risk and conservative capital structure. • Liquidity and Cash Position: $19.4 million in cash and short-term investments as of Q1 2025, with a current ratio of 2.89, indicating strong ability to meet short-term obligations • Debt Level: Virtually debt-free with debt-to-equity ratio of only 0.001, eliminating financial leverage risk • Cash Flow: Generated $13.0 million in operating cash flow for fiscal 2024, though Q1 2025 showed temporary negative free cash flow of -$2.4 million due to facility investments • Valuation Metrics: Trading at 25.5x P/E ratio and 54.3x EV/EBITDA based on Q1 2025 results, suggesting elevated valuation levels relative to earnings • Profitability: Maintained consistent profitability with 4.8% ROE, though margins can be volatile due to commodity price fluctuations • Other Considerations: Graham Net-Net ratio of 1.16 suggests reasonable asset backing, while the company's niche market position provides some protection during economic downturns as health-conscious consumers tend to maintain spending on wellness products
Recent development
Over the past few years, Lifeway Foods has pursued several key strategic initiatives focused on product innovation, market expansion, and operational efficiency. The company has significantly expanded its product portfolio with lactose-free organic kefir products, addressing a growing consumer demand for dairy alternatives while maintaining the probiotic benefits of traditional kefir. New flavor innovations include unique offerings like Hot Honey, Matcha Latte, and Passionfruit Lychee, targeting younger and more adventurous consumers. The company has made substantial investments in production capacity expansion, particularly at its Waukesha, Wisconsin facility, which is expected to double manufacturing capacity and support future growth. This expansion is part of management's goal to achieve $45-50 million in adjusted EBITDA by fiscal year 2027. Distribution expansion has been a major focus, with Lifeway successfully entering new retail channels including CVS pharmacies, expanding presence in Target and Walmart stores, and growing the Farmer's Cheese line to 1,400 Albertsons locations. The company has also pursued international expansion, entering new markets in South Africa and the UAE. Marketing strategy has evolved to emphasize health and wellness positioning, particularly targeting consumers using GLP-1 medications for weight management, as kefir's protein content and probiotic benefits align well with their nutritional needs. The company has increased investment in digital marketing, influencer partnerships, and experiential marketing events while reducing its reliance on lower-margin private-label manufacturing to focus resources on higher-margin branded products.
LWAY company profile · for informational purposes only — not investment advice.
Track LWAY with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free